Companies: 10,795·Total market cap: $144.5T
Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc.

ASBPNASDAQHealthcare● Active
$6.65
+$1.31(+24.53%)
Market Cap$767224
P/E Ratio—
52W High$35
52W Low$0.11
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Aspire Biopharma Holdings, Inc.（ASBP）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ASBP · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-8.41asbp eps ttm · asbp earnings per shareEarnings history
PE Ratio (TTM)—asbp pe ratio ttm · asbp price to earningsPE Ratio deep dive
Revenue (TTM)34555.00asbp revenue ttm · asbp annual revenueFull revenue history
Dividend Yield不分红does asbp pay dividends · asbp dividend yieldDividend history
Shares Outstanding1.5Masbp shares outstanding · asbp floatShares outstanding history
Next EarningsTBAasbp earnings date · asbp next earningsEarnings history

探索 Aspire Biopharma Holdings, Inc. 数据

asbp stock data · financials
市值$767,224asbp market cap · asbp valuation
分析师预测—
股息不分红does aspire biopharma holdings, inc. pay dividends · asbp dividend yield
营收$6202aspire biopharma holdings, inc. annual revenue · asbp revenue
盈利EPS $-16.38+9.85%asbp earnings · asbp eps
市盈率—asbp pe ratio · asbp price to earnings

财务快照

完整财报
FY 2025Revenue$6202.00
202320242025
aspire biopharma holdings, inc. revenue · asbp revenue 2025
FY 2025Net Income-$24.5M▼ 95.27% YoY
202320242025
aspire biopharma holdings, inc. net income · asbp profit 2025
FY 2025EPS$-16.38▲ +9.85% YoY
202320242025
asbp eps · aspire biopharma holdings, inc. earnings per share 2025
TTM:Revenue: $34555.00Net Income: -$11.8MEPS: $-8.41View income statement →

股票表现

完整历史
1D+24.53%
1W+13.10%
1M+19.82%
3M-80.89%
YTD-95.80%
1Y-98.60%
5Y-99.94%

关于 Aspire Biopharma Holdings, Inc.

CEOKraig T. Higginson
IPO DateFeb 20, 2025
Employees2
CountryUS
Websiteaspirebiolabs.com

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship …

BiotechnologyHealthcareNASDAQUS

what is aspire biopharma holdings, inc. · asbp stock overview · aspire biopharma holdings, inc. company profile · who is aspire biopharma holdings, inc. ceo · asbp NASDAQ · aspire biopharma holdings, inc. headquarters · aspire biopharma holdings, inc. business segments

关于股票概览与关键数据

Aspire Biopharma Holdings, Inc.（ASBP）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 20, 2025 在 NASDAQ 上市。截至最近交易日，ASBP 股价为 $6.65，市值约为 $767,224。过去12个月累计回报 -98.60%，年初至今回报 -95.80%。

2025 财年 Aspire Biopharma Holdings, Inc. 营收 $6202.00。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Aspire Biopharma Holdings, Inc.（ASBP）股价为 $6.65，在 NASDAQ 上市，52周区间为 $0.11 – $35.00。

ASBP 最新股价ASBP quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议